SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Izzy who wrote (5329)9/18/1998 2:37:00 PM
From: Izzy  Read Replies (2) | Respond to of 6136
 
Possible supplemental alternatives with possible anti-HIV activity (inhibition of reverse transcriptase): Compound Q, quercetin (bioflavinoid; antioxidant), and baicalin (flavinoid available in the Japanese herbal mixture named Sho-saiko-to). Also, high dose B complex vitamins may prevent increased blood lactic acid levels in those people taking nucleosides ("nukes"). I found this info at web site: catie.ca Steve, appreciate your reply. BTW, have noticed that TBR has been on a great run; hope you were able to enjoy the ride (I didn't buy; was just watching, as usual).



To: Izzy who wrote (5329)9/18/1998 9:36:00 PM
From: Elmer  Read Replies (1) | Respond to of 6136
 
Hi Izzy,
GLX is trying to get "late breaker" admission to a conference starting Sept. 24 to present phase III results on VRTX's PI. If they are accepted, VRTX could be strong next week.

What I find weird about the recent price strength in VRTX is that it has come on low volume. So, at least so far, the institutions don't appear to be loading up.

David


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News